tradingkey.logo
tradingkey.logo
Pesquisar

Upexi Inc

UPXI
Adicionar à lista de desejos
1.450USD
-0.070-4.61%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
101.88MValor de mercado
PerdaP/L TTM

Mais detalhes de Upexi Inc Empresa

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Informações de Upexi Inc

Código da empresaUPXI
Nome da EmpresaUpexi Inc
Data de listagemJun 24, 2021
CEOMarshall (Allan)
Número de funcionários59
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 24
Endereço3030 Rocky Point Drive
CidadeTAMPA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal33607
Telefone17013535425
Sitehttps://upexi.com/
Código da empresaUPXI
Data de listagemJun 24, 2021
CEOMarshall (Allan)

Executivos da empresa Upexi Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.31M
+6.04%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+14.59%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+40.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.31M
+6.04%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+14.59%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+40.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q1
Por EmpresaUSD
Nome
Receita
Proporção
Internally manufactured
2.04M
70.03%
Contract manufactured
855.12K
29.40%
Purchased as finished goods
16.63K
0.57%
Por RegiãoUSD
Nome
Receita
Proporção
United States of America
2.86M
98.37%
Other
47.46K
1.63%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Internally manufactured
2.04M
70.03%
Contract manufactured
855.12K
29.40%
Purchased as finished goods
16.63K
0.57%

Distribuição de ações

Atualizado em: qui, 14 de mai
Atualizado em: qui, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Samara Special Opportunities
6.44%
Vanguard Capital Management, LLC
4.81%
Marshall (Allan)
4.72%
Arrington Capital Investment Management, LLC
3.93%
GSR Growth Investments LP
3.82%
Outro
76.27%
Investidores
Investidores
Proporção
Samara Special Opportunities
6.44%
Vanguard Capital Management, LLC
4.81%
Marshall (Allan)
4.72%
Arrington Capital Investment Management, LLC
3.93%
GSR Growth Investments LP
3.82%
Outro
76.27%
Tipos de investidores
Investidores
Proporção
Investment Advisor
16.79%
Corporation
10.78%
Individual Investor
8.43%
Hedge Fund
8.35%
Investment Advisor/Hedge Fund
5.62%
Research Firm
2.91%
Bank and Trust
0.40%
Venture Capital
0.23%
Pension Fund
0.15%
Outro
46.33%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
122
23.05M
34.45%
-188.43K
2025Q4
98
14.39M
22.84%
-8.99M
2025Q3
60
18.50M
31.42%
+11.94M
2025Q2
46
10.18M
21.50%
+7.63M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Samara Special Opportunities
4.53M
7.16%
+4.53M
--
Aug 29, 2025
Marshall (Allan)
3.31M
5.24%
+200.00K
+6.42%
Dec 23, 2025
Arrington Capital Investment Management, LLC
2.76M
3.96%
+2.76M
--
Dec 31, 2025
GSR Growth Investments LP
2.69M
4.25%
+380.35K
+16.49%
Sep 30, 2025
MMCAP Asset Management
766.93K
1.21%
-12.17M
-94.07%
Sep 30, 2025
Millennium Management LLC
365.96K
0.58%
-19.30K
-5.01%
Sep 30, 2025
Rudick (Brian Benjamin)
838.60K
1.33%
+400.00K
+91.20%
Jul 16, 2025
Susquehanna International Group, LLP
751.48K
1.19%
+637.36K
+558.48%
Sep 30, 2025
Qube Research & Technologies Ltd
744.44K
1.07%
+744.44K
--
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Data
Data ex-dividendo
Tipo
Proporção
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
KeyAI